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Oleate but not stearate induces the 
regulatory phenotype of myeloid 
suppressor cells
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Tumor infiltrating myeloid cells play contradictory roles in the tumor development. Dendritic cells 
and classical activated macrophages support anti-tumor immune activity via antigen presentation 
and induction of pro-inflammatory immune responses. Myeloid suppressor cells (MSCs), for instance 
myeloid derived suppressor cells (MDSCs) or tumor associated macrophages play a critical role in 
tumor growth. Here, treatment with sodium oleate, an unsaturated fatty acid, induced a regulatory 
phenotype in the myeloid suppressor cell line MSC-2 and resulted in an increased suppression of 
activated T cells, paralleled by increased intracellular lipid droplets formation. Furthermore, sodium 
oleate potentiated nitric oxide (NO) production in MSC-2, thereby increasing their suppressive capacity. 
In primary polarized bone marrow cells, sodium oleate (C18:1) and linoleate (C18:2), but not stearate 
(C18:0) were identified as potent FFA to induce a regulatory phenotype. This effect was abrogated in 
MSC-2 as well as primary cells by specific inhibition of droplets formation while the inhibition of de novo 
FFA synthesis proved ineffective, suggesting a critical role for exogenous FFA in the functional induction 
of MSCs. Taken together our data introduce a new unsaturated fatty acid-dependent pathway shaping 
the functional phenotype of MSCs, facilitating the tumor escape from the immune system.
Obesity has been identified as an independent risk factor for a variety of cancers including colorectal cancer1–3. 
However the mechanisms driving this pro-tumorigenic state have not been entirely elucidated. The visceral fat 
tissue is the source of a number of soluble mediators including cytokines, adipokines as well as chemokines that 
determine the local milieu. For example the pro-inflammatory milieu in the visceral fat tissue in obesity has been 
identified as key factor for insulin resistance4, 5. Besides the described soluble mediators, the visceral fat tissue 
is the primary source for free-fatty acids (FFA)6, 7. Remarkably, while adipose tissue is the main site of fatty acid 
synthesis in mammals, tumor tissue itself has been revealed to be a source of FFA suggesting that FFA themselves 
might have the potential to determine the local milieu and hence tumor growth7, 8.
During the last decade, two emerging hallmarks have been added to the classical hallmarks of cancer, namely 
reprogramming of energy metabolism and evading immune destruction9. Here, especially the lipid metabolism 
of tumor cells has been addressed in several studies and could be identified as crucial factor for further tumor 
progression10, 11. For example, FFA released by human breast cancer tissue sufficed to suppress cytotoxic T cell 
responses suggesting that FFA can directly modulate the anti-tumor response8. Additional data from 1970s indi-
cate that not FFA in general but rather defined FFA are responsible for this observed immunosuppressive effect. 
Here, an increased number of experimental tumors were observed after an exposure to oleate-enriched diet12. 
Furthermore, an epidemiological study showed that patients within the highest quartile of oleic acid content 
(>38% of total adipose tissue fatty acids) bear 7.5 time higher probability of metastatic lymph nodes than the 
patients in the lower quartile (<35% of total adipose tissue fatty acids)6.
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Which cells represent the primary target for the FFA-mediated effects? A recent study provides evidence that 
dendritic cells from tumor bearing mice or cancer patients are characterized by high amounts of triglycerides, 
caused by an increased uptake of extracellular lipids. These dendritic cells were not only characterized by lipid 
droplets, the accumulation of intracellular FFA, but furthermore lost their ability of cross presentation that ulti-
mately led to tumor progression13, 14. These data indicate that myeloid cells represent a target population for FFA.
The heterogeneity of tumor infiltrating myeloid cells link to their contradictory immune function in the tumor 
microenvironment15. Myeloid derived suppressor cells (MDSCs) and tumor associated macrophages (TAMs) 
represent the two major inhibitory myeloid populations in the tumor. These two subsets share several common 
mechanisms to regulate T cell responses including NO release, arginine deprivation via arginase, the aggressive 
activation of indoleamine-pyrrole 2,3-dioxygenase (IDO) and the synthesis of peroxyntitrite (PNT). Besides, a 
subset of MDSCs (M-MDSCs) differentiate rapidly into TAMs after migrating into tumor site indicating a close 
correlation between these two cell types16. However, which factor(s) derived from tumor milieu leading to the 
potent suppressive capacity of myeloid cells is still unclear.
Thus in the present study, the MSC-2 cell line as well as primary bone marrow-derived myeloid cells served 
to elucidate the effect of specific FFA on MSCs function. Our data indicate that in particular sodium oleate, an 
unsaturated FFA, induces an inhibitory function in both cell line and primary cells. This inhibitory effect was 
controlled by the amount of intracellular FFA and by droplets formation. Sodium oleate-dependent induction 
of NO was revealed as the central mechanism mediating this inhibitory function. Thus we here suggest a novel 
sodium oleate-dependent pathway to induce MSCs.
Results
Sodium oleate is sufficient to induce a regulatory phenotype in MSC-2 cells. The MSC-2 cell line 
served to investigate the regulatory mechanisms of myeloid suppressor cells (MSCs). As described previously17, 
when cultured in the presence of IL-4, MSC-2 cells differentiated into a regulatory phenotype, accompanied by 
up-regulation of CD80, MHCII, CD4 and CD11b (data not shown). Functionally, these MSC-2 cells inhibited T 
cell proliferation (Fig. 1A) paralleled by a strong increase in arginase activity (Fig. 1B). Hence in the following 
experiments IL-4-treated MSC-2 cells served as positive control for regulatory myeloid cell function.
It was previously reported, that accumulation of lipid droplets is paralleled by dendritic cell dysfunction13. 
Free fatty acids (FFA) represent one of the most important sources for the synthesis of intracellular lipid droplets. 
In the presence of sodium oleate, MSC-2 cells resembled the above-introduced positive control with regard to 
their suppressive capacity. This regulatory function, as evaluated by suppression of T cell proliferation, could 
be induced in a dose-dependent manner and was completely independent of endogenous IL-4, since the pres-
ence of neutralizing IL-4 antibodies did not abolish the regulatory properties (Fig. 1C). The transition from 
non-regulatory myeloid cells to functional suppressor cells seemed to be restricted to MSC-2 cells, since the 
macrophage cell line RAW264.7 did not differentiate into a regulatory phenotype in the presence of sodium oleate 
(Supp. Figure 1).
Sodium oleate but not stearate induces a regulatory phenotype in MSC-2 cells. Both saturated 
and unsaturated fatty acids serve as metabolic components and can be stored as lipid droplets in conditions 
of nutritional satisfaction18. To explore the potential regulatory role of saturated and unsaturated fatty acids, 
MSC-2 cells were cultured in the presence or absence of either sodium oleate (C18:1) or sodium stearate (C18:0). 
Even though both fatty acids shared the ability of droplets formation as detected by either oil-red-O or BODIPY 
staining (Fig. 2A), only the presence of sodium oleate, but not sodium stearate, sufficed to induce the regulatory 
phenotype as indicated by the inhibitory effect on T cell proliferation (Fig. 2B).
Sodium oleate-induced regulatory phenotype of MSC-2 cells depends on NO production but 
not arginase activity. The suppressive effect of MDSC has been described to rely on two mechanisms: 
Release of NO to block the activation of the IL-2 signaling pathway in T cells and a boost in arginase activity 
to exhaust arginine, which is crucial for the synthesis of the CD3ζ chain19. To explore the mechanism by which 
sodium oleate induced the regulatory phenotype, both NO production and arginase activity were analyzed. The 
presence of sodium oleate did not suffice to elicit arginase activation (Fig. 3A), hence excluding arginase activity 
as potential mechanism of the regulatory function.
However, in the T cell co-culture system as well as after stimulation with IFNγ, the presence of sodium oleate 
resulted in a significant increase in NO production (Fig. 3B/C). Unspecific endotoxin effects were excluded by 
performing the experiment in the presence of the LPS-blocking reagent polymyxin B (Fig. 3D).
In contrast, sodium stearate failed to induce NO production (Fig. 3C). This was further supported by the high 
expression of iNOS in IFNγ-stimulated MSC-2 cells in the presence of sodium oleate but not sodium stearate 
(Fig. 3E). In line, the sodium oleate-mediated regulatory effect of MSC-2 cells in the T cell proliferation assay 
could be neutralized either by L-NMMA, an inhibitor of the NO synthase or in the presence of an IFNγ neutral-
izing antibody (Fig. 3F/G). In addition, the NO-dependency of this sodium oleate-mediated regulatory function 
was further supported by comparing MSC-2 and RAW264.7 cells. Here RAW264.7 cells failed to produce NO in 
the presence of sodium oleate and subsequently failed to suppress T cell proliferation (Supp. Figure 1B/C).
The suppressive capacity of MSC-2 cells relies on the presence of lipid droplets. Uptake of FFA 
led to the accumulation of lipid droplets in the cytoplasm. Once sodium oleate had been removed from the 
medium, MSC-2 cells consumed their lipid droplets within 72 h (Fig. 4A). This loss of lipid droplets, as deter-
mined by flow cytometry, correlated with the reduction of NO production (Fig. 4C) and subsequently with the 
loss of suppressive capacity of these cells in the T cell proliferation assay (Fig. 4B).
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Diacylglyercol acyltransferase-dependent lipid droplets formation controls the effect of 
sodium oleate on MSC-2 cells. While tumor cells are capable of de novo fatty acid synthesis, tumor stroma 
cells prefer the uptake of exogenous FFA20. Acetyl-CoA carboxylase (ACC) catalyzes the irreversible carbox-
ylation of acetyl-CoA to malonyl-CoA, which is the most important element for de novo fatty acid synthesis. 
Here the specific inhibitor of ACC, 5-(tetradecyloxy)-2-furoic acid (TOFA), served to investigate the role of de 
novo fatty acids with regard to the sodium oleate-induced suppressive effect. The presence of TOFA reduced the 
sodium oleate-induced lipid droplets formation, paralleled by a modest reduction of the inhibitory function of 
these MSC-2 cells (Fig. 5A/B). These results exclude an exclusive role of de novo fatty acid synthesis in mediating 
the suppressive capacity of sodium oleate-induced MSC-2 cells. The enzymes directly connected to the lipid 
droplets accumulation are the diacylglycerol acyltransferases (DGAT) 1 and DGAT2. Harris et al. proved that 
the accumulation of lipid droplets in adipocytes was only diminished in DGAT1 and DGAT2 double knockout 
(KO) but not in single KO mice21, indicating a potent compensatory mechanism between the two enzymes. In 
line, our own data demonstrated that only the combined inhibition of both DGAT by iDGAT (400 nM) sufficed to 
abolish sodium oleate-induced lipid droplets formation in MSC-2 cells (Fig. 5C/D). In parallel, with lipid droplets 
formation, the presence of iDGAT impaired the inhibitory function of these cells (Fig. 5E/F) as well as the NO 
production in the co-culture supernatants (Fig. 5G). These results suggest that not only the presence of distinct 
free fatty acids in the cytoplasm but also the lipid droplets formation itself mediates the regulatory phenotype of 
MSC-2 cells.
Figure 1. Sodium oleate is sufficient to induce a regulatory phenotype in MSC-2 cells. MSC-2 cells were 
incubated in the presence or absence of IL-4 (100 ng/ml) for four days as indicated, followed by the analysis of 
their inhibitory potency: Purified CD4+ T cells were co-cultured with MSC-2 cells in the presence or absence of 
IL-4 in a ratio of 1:5. T cell proliferation was analyzed by CFSE staining after 72 h (A). After a four-day culture 
of MSC-2 cells in the presence or absence of IL-4 (100 ng/ml), arginase activity was determined (B). Purified 
CD4+ T cells were co-cultured with MSC-2 cells in the presence or absence of IL-4, sodium oleate (0.2 mM) or a 
neutralizing IL-4 antibody (10 µg/ml) as indicated. T cell proliferation was analyzed by CFSE staining after 72 h 
(C). Shown is the mean ± SD from two to three independent experiments. *p ≤ 0.05; **p ≤ 0.01.
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Both sodium oleate and sodium linoleate induce a regulatory phenotype in bone marrow- 
derived myeloid cells. As adult primary myeloid cells, suppressive or non-suppressive, were not affected 
by the presence of sodium oleate (Supp. Figure 2), we chose to differentiate suppressive myeloid cells from bone 
marrow precursors. Modifying a GM-CSF-based protocol22, 23, myeloid cells were derived from the bone marrow 
of healthy wild type mice as described in the methods section in the presence of either sodium oleate, sodium 
stearate or BSA as vehicle control. When analyzed in a T cell proliferation assay, the sodium oleate-treated cells 
confirmed their MSC-phenotype, while the sodium stearate- as well as BSA-treated groups failed to affect T cell 
Figure 2. Sodium oleate but not stearate induces a suppressive phenotype in MSC-2 cells. MSC-2 cells were 
incubated for 24 h with either sodium oleate (0.2 mM) or stearate (0.2 mM). The accumulation of lipid droplets 
was detected either microscopically via oil-red-O (×20), or by BODIPY staining and flow cytometry (A). To 
assess the inhibitory effect of either sodium oleate or stearate, MSC-2 cells, pre-treated with the respective 
FFA, were subsequently co-cultured with purified CD4+ T cells at the ratios indicated. T cell proliferation was 
analyzed by CFSE staining after 72 h (B). Shown is the mean ± SD from three to four independent experiments. 
**p ≤ 0.01; ***p ≤ 0.001.
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proliferation (Fig. 6A). This effect was again paralleled by a significantly enhanced NO production of the sodium 
oleate-treated cells as compared to the sodium stearate or BSA groups, hence confirming the successful genera-
tion of primary MSCs from bone marrow precursors via the presence of sodium oleate (Fig. 6B). Furthermore, 
the supernatant of myeloid-T cell co-culture system from oleate group contained a dramatically reduction of 
IFNγ, the dominant cytokine released from activated T cells, validating the regulatory effect of oleate on myeloid 
cells (Fig. 6C). Here, treatment with the unsaturated fatty acid (18:2) sodium linoleate was equal to the effect 
induced by sodium oleate: the bone marrow-derived myeloid cells developed an immunosuppressive phenotype 
(Fig. 6D/E).
Gr1− but not Gr1+ cells exhibit enhanced immunosuppressive capacity after oleate treatment. 
To identify the suppressive subsets in primary myeloid cells after oleate treatment, Gr1+ and Gr1− cells were 
sorted for functional analysis (Supp. Figure 3). Although Gr1+ cells accumulated after oleate treatment (Supp. 
Figure 4), these cells failed to suppress T cell proliferation in the ratio of 1:10. In contrast, oleate potentiates the 
inhibitory capacity of Gr1− cells as well as their NO production (Fig. 7A/B). E.G7-OVA cell line was used here to 
test the impact of polarized myeloid cells on the cytotoxicity of T lymphocytes (CTLs). In contrast to the CTLs 
coincubated with BSA pretreated myeloid cells, OVA specific cytotoxicity of CTLs was decreased significantly 
Figure 3. The sodium oleate-induced regulatory phenotype of MSC-2 cells depends on NO production but 
not arginase activity. MSC 2 cells were cultured in the presence of either IL-4 (100 ng/ml), BSA (Con) or 
sodium oleate (0.2 mM). After 24 h arginase activity was determined (A). MSC-2 cells were co-cultured with 
purified CD4+ T cells for 72 h in the presence of either BSA, sodium oleate (0.2 mM) or IL-4 (100 ng/ml) and 
NO was measured via Griess reagents in the supernatant (B). MSC-2 cells were stimulated with the indicated 
concentrations of IFNγ for 24 h in the presence of either BSA (Con), sodium oleate (0.2 mM), sodium stearate 
(0.2 mM), IL-4 (100 ng/ml) and IFNγ as indicated. NO was measured via Griess reagents in the supernatant (C). 
MSC-2 cells were treated with BSA (Con), sodium oleate (0.2 mM) in the presence or absence of IFNγ (10 ng/ml) 
and polymyxin B (10 µg/ml) as indicated (D). MSC-2 cells were pretreated overnight with BSA (C), sodium 
oleate (O) or sodium stearate (S) and subsequently stimulated for 8 h with IFNγ (1 ng/ml). Cell lysates were 
analyzed by Western blot analysis for iNOS as well as beta-actin expression. Quantitative evaluation in relation 
to β-actin expression was performed. Shown is the mean ± SD of n = 2 experiments (E). MSC-2 cells were co-
cultured with CD4+ T cells in the ratios indicated and in the presence or absence of BSA (Con), sodium oleate 
(0.2 mM) and the iNOS inhibitor L-NMMA (2.5 mM) (F) or anti-IFNγ (10 µg/ml) (G). Cell proliferation was 
evaluated by CFSE staining after 72 h. Shown is the mean ± SD from two to four independent experiments. 
*p < 0.05; **p < 0.01; ***p < 0.001.
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after coculture with oleate pretreated Gr1− populations (Fig. 7C). Phenotypically, Gr1+ cells express low levels 
of CD11b, CD80 and CD86 and are negative for CD11c, F4/80, CD163 and CD206. These results suggested 
that accumulated Gr1+ cells in the oleate group are immature myeloid cells but neither DCs nor macrophages. 
Notably, the surface marker expression panel of Gr1− cells resembles the one from the MSC-2 cell line, includ-
ing diminished Gr1 expression and upregulated F4/80. Oleate treatment elevated the expression of CD163 and 
CD206 paralleled by a reduction of MHCII, indicating a conversion of the myeloid cell phenotype from antigen 
presenting into immune regulating (Fig. 7D). Cytokine detection via cytometric bead array (CBA) proved an 
oleate specific induction of IL-6 and TNFα. A significant increasing of IL-1β was induced by both oleate and 
stearate, although the concentration was negligible compared with either TNFα or IL-6. IL-4 and IFNγ were not 
detectable in all the groups (Fig. 7E).
Inhibition of DGAT reverses the induction of a regulatory phenotype on primary cells by sodium 
oleate. To validate the effect of DGAT on primary bone marrow cells, iDGAT was added in the presence of 
sodium oleate to the polarizing cells and the emerging phenotype was analyzed. Again, DGAT function proved 
to be essential for T cell suppression, NO production as well as lipid droplets formation of the primary MSCs. 
(Fig. 8A–C). Remarkably, oleate treatment induces lipid droplets formation in Gr1− but not Gr1+ cells, which 
again is impaired by iDGAT treatment effectively. These results validate that oleate represents a functional inducer 
of the immunosuppressive phenotype, primarily targeting Gr1− cells (Fig. 8C).
Discussion
Remarkably, different free fatty acids (FFA) fulfill diverse biological functions according to their saturation 
state. For example, high doses of saturated FFA exhibit a toxic effect on human bone marrow mesenchymal 
stem cell viability, which can be reversed by adding unsaturated fatty acids24. Furthermore the selective inhi-
bition of stearoyl Co-A desaturase, the key enzyme to catalyze stearate into oleate, induces an elimination of 
human pluripotent stem cells25. This phenomenon has been associated with the occurrence of endoplasmatic 
reticulum stress, which is directly regulated by the ratio of cytoplasmic saturated and unsaturated fatty acids26. 
Focusing on the impact of fatty acids on myeloid cells, it has been described, that palmitate triggers the trans-
formation of macrophages and Kupffer cell into pro-inflammatory cells whereas oleate promotes the expression 
of anti-inflammatory markers27. In addition, oleic and stearic acid induce differential effects also in neutrophils, 
as indicated by diverse phagocytosis and candidacidal effects28. Both fatty acids can be found in tumor tissue in 
different concentrations. In ovarian cancer tissue, the amounts of stearate and oleate are both about 100 µM, com-
pared to 80 µM stearate and 40 µM oleate in benign tissue11. Also, breast cancer tissue shows a 100 fold increase in 
the release of oleate compared to benign breast tissue8. In Ehrlich ascites tumor model, the concentration of FFAs 
Figure 4. Kinetic of lipid droplets formation and suppressive capacity after sodium oleate treatment. MSC-2 
cells were cultured in the presence or absence of sodium oleate (0.2 mM) for 24 h. Cells were washed and left in 
BSA-medium for up to 72 h and the analysis was performed at the time points indicated. The formation of lipid 
droplets (A) were analyzed by BODIPY staining. The regulatory function of MSC-2 cells from those groups was 
analyzed via T cell proliferation assay (B). Supernatant from the co-culture served for the quantification of NO 
production (C). Shown is the mean ± SD from two to three independent experiments. ***p ≤ 0.001.
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Figure 5. Diglyceride acyltransferase (DGAT) dependent lipid droplets formation controls the effect of sodium 
oleate on MSC-2 cells. MSC-2 cells were incubated with TOFA (5 µg/ml) in the presence or absence of sodium 
oleate (0.2 mM). Droplets formation was evaluated by BODIPY staining and flow cytometry (A). MSC-2 cells 
were incubated in the presence or absence of sodium oleate and TOFA as indicated and were subsequently 
stimulated with IFNγ (1 ng/ml) for 24 h. NO production was determined (B). MSC-2 cells were co-cultured 
with CD4+ T cells in the ratios as indicated and in the presence or absence of TOFA (5 µg/ml). Cell proliferation 
was evaluated by CFSE staining after 72 h (C). Combination of DGAT inhibitors was added together with 
sodium oleate for 24 h, the lipid droplets formation was analyzed via BODIPY staining (D, E). Functional 
assay was also performed in the co-culture system with CD4+ T cells: the proliferation of T cells (F, G) and 
the production of NO in the co-culture wells (H) were measured. Shown is the mean ± SD from two to four 
independent experiments. *p < 0.05; **p < 0.01; ***p < 0.001.
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in ascites fluid of tumor bearing mice is about 0.244 mM7, containing 32.2% oleate and 12.6% stearate. To induce 
lipid droplets, a range from 0.2 mM to 0.6 mM oleate has been used in different cell types in vitro13, 29, which was 
also used in the present study.
This study adds further evidence to distinguish the diverse function of sodium oleate and stearate. The pres-
ence of both long chain fatty acids resulted in the formation of lipid droplets in the MSC-2 cell line, however 
the impact on cell function was very different. Here only the presence of sodium oleate but not sodium stearate, 
mediated an inhibitory function in the MSC-2 cell line as well as in bone marrow-derived macrophages in the T 
cell proliferation assay. In line, only sodium oleate treatment led to an increase of nitric oxide (NO) production, a 
previously described mechanism for MDSC to suppress T cell activation and proliferation.
NO is known to be one of the most versatile players in the immune system. It has been shown to be involved 
in the pathogenesis and control of infectious diseases, tumors, autoimmune processes and chronic degener-
ative diseases30. NO has been considered pro-inflammatory for its anti-microbial effect and at the same time 
anti-inflammatory for its regulatory capacity30. Macrophage-derived NO suppresses T cell activation via a revers-
ible disruption of the Jak3/STAT5 signaling pathway31 and MDSC-derived NO has been described to suppress 
T cell proliferation by blocking the IL-2 signaling pathway32. The IFNγ signaling pathway is well characterized 
as an important pathway initiatiating NO production. In this manuscript, we also found that IFNγ neutraliza-
tion blocked the oleate induced suppressive phenotype of MSC-2 cells, indicating an essential role of IFNγ on 
the inhibitory function of myeloid cells. However, downstream events of the IFNγ signaling pathway, includ-
ing phosphorylation of STAT1 and STAT3, were not altered by oleate treatment (Supp. Figure 5). Interestingly, 
IFNγ stimulation elevated the expression of IFNγ receptor CD119 on RAW264.7 but not MSC-2 cell line (Supp. 
Figure 5). According to the significant upregulation of iNOS expression (Fig. 3E) and NO production in both, cell 
line and primary myeloid cells, after oleate treatment, we conclude that IFNγ acts as an initiator but not an oleate 
associated regulator for NO production. In other words, IFNγ signaling does not regulate the concentration of 
NO after starting the production in myeloid cells. This conclusion can be supported by the quantification of IFNγ 
in the supernatants of T cell - myeloid cell cocultures, where oleate pretreated myeloid cells show a decreased 
amount of IFNγ accompanied with an increased amount of NO. And both, TOFA and DGAT inhibitors, which 
could block lipid droplet formation, also impaired the production of NO in MSC-2 cell line and primary myeloid 
cells. Suggesting that the NO mediated immune suppression after the initiation of IFNγ is controlled by the lipid 
metabolism.
Phenotypically, the induction of an inhibitory phenotype in MSC-2 cells was accompanied by the formation 
of lipid droplets in our model. Previous studies in tumor immunology revealed that the accumulation of lipid 
droplets in dendritic cells impaired their ability of antigen cross presentation, which in turn promoted tumor 
Figure 6. Both sodium oleate and sodium linoleate induces a regulatory phenotype in bone marrow-derived 
myeloid cells. Bone marrow cells isolated from naïve mice were cultured with GM-CSF (40 ng/ml) and FFA as 
indicated for 7 days. FFA-treated cells or controls were co-cultured with CD4+ T cells in the ratios as indicated. 
Cell proliferation was evaluated by CFSE staining after 72 h (A/E). Supernatants were served for NO analysis 
(B/F) and IFNγ detection (C). Shown is the mean ± SD from two to four independent experiments. *p < 0.05; 
**p ≤ 0.01;***p ≤ 0.001.
www.nature.com/scientificreports/
9SCIentIFIC RepORtS | 7: 7498  | DOI:10.1038/s41598-017-07685-9
progression13. Here, the reduction of lipid droplet formation via TOFA, contributed to the recovery of antigen 
presentation in dendritic cells. While we could confirm a correlation between lipid droplet formation in MSC-2 
cells and an increase in the suppressive capacity, the data from sodium stearate treatment are contradictory. This 
led to question, whether lipid droplet formation itself or rather a metabolic effect, introduced by the presence of a 
Figure 7. Gr1− but not Gr1± cells exhibit enhanced immunosuppressive capacity after oleate treatment. Bone 
marrow cells were polarized in the presence of 40 ng/ml GM-CSF and treated with the indicated compounds 
for 7 days. Gr+ and Gr1− populations were purified via beads and co-cultured with purified CD4+ T cell in the 
ratios indicated for functional assay (A). NO production from the co-culture supernatant was quantified by 
Griess reaction (B). CTLs were polarized and coincubated with purified Gr1− cells for 18 hours. The suspension 
cells were harvested and cocultured with CFSE labelled E.G7 OVA cell line for 90 mins. The proportion of 
Annexin V+ cells gated from CFSE+ population was used to calculate the cytotoxicity of CTLs (Formula in the 
Methods section) (C). Surface marker panel of Gr1− cells from either control or oleate group was performed 
via flow cytometry (D). Purified Gr1− cells were stimulated by 1 µg/ml LPS in 24 hours and then supernatants 
were collected for cytokine analysis (E). Shown is the mean ± SD from two to four independent experiments. 
*p < 0.05; **p ≤ 0.01;***p ≤ 0.001.
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defined FFA mediates the regulatory phenotype. As described above, TOFA inhibits de novo fatty acid synthesis, 
hence it directly affects the FFA concentration in the cytoplasm. However, this does not allow for distinguishing 
in between the effect of FFA or lipid droplet formation in the cytoplasm. Inhibition of DGAT1 and DGAT2, both 
are required for the formation of lipid droplets21, allows for confining the effect of FFA versus lipid droplets. Thus 
the experiments with DGAT1&2 inhibitors clearly proved that the suppressive phenotype depends on the forma-
tion of lipid droplets in the cells.
In contrast to tumor cells which are able to synthesize and release fatty acids, immune cells prefer the uptake 
of exogenous fatty acids20, 33. According to our data, the inhibition of de novo fatty acid synthesis by TOFA proved 
less efficient than inhibition of DGAT1/2. Thus we consider the presence and incorporation of exogenous fatty 
acids as critical for the functional induction of myeloid suppressor cells. Blocking the induction of regulatory cells 
by DGAT inhibitors should be considered as a novel therapeutic strategy for solid tumors.
However, the analysis of primary CD11b+ cells isolated from the tumor site of tumor-bearing mice, indicate 
that exogenous FFA cannot further increase the inhibitory function of already immunosuppressive cells (Supp. 
Figure 2). This implies that myeloid cells from the tumor site are either already saturated with exogenous FFA or 
represent mature cells, which simply cannot be shaped into a regulatory phenotype.
There are several published protocols to generate myeloid suppressor cells in vitro22, 34. In all the protocols, 
GM-CSF performed as a central cytokine during the differentiation of myeloid cells into immunosuppressive cells. 
In contrast to the time course for MDSC induction (3–4 days), in our hands GM-CSF was sufficient to induce 
the polarization of CD206+ macrophages in seven days (data not shown). With this protocol, an accumulation of 
Figure 8. Inhibition of DGAT impedes the impact of sodium oleate on primary cells bone marrow cells. Bone 
marrow cells were polarized in the presence of 40 ng/ml GM-CSF and treated with the indicated compounds for 
7 days. Functional assay was performed via co-culture with purified CD4+ T cell in the ratios indicated (A). NO 
production from the co-culture supernatant was quantified by Griess reaction (B). BODIPY staining was used 
to detect the lipid droplets formation in variant subpopulation of primary bone marrow cells (C). Shown is the 
mean ± SD from two to four independent experiments. *p < 0.05.
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Gr1+ cells could be found after oleate treatment, but this population did not exhibit a potent immunosuppressive 
capacity (Fig. 7; Supp. Figure 4). Therefore, although CD11b and Gr1 are widely used as MDSC markers, we 
would not consider them as MDSC. On the other hand, our protocol indeed induced strong immunosuppressive 
cells from bone marrow in the presence of oleate but not stearate. But as the sorting experiment demonstrated, the 
Gr1− cells are actually the ones which occupy the dominant place in oleate induced inhibition of primary T cells. 
This Gr1− population shows an about 10 fold higher suppressive capacity compared to the Gr1+ populations. 
Interestingly, the data from Gr1− cells matched exactly all the findings in the MSC-2 cell line. Although MSC-2 
is a well-accepted cell line to represent MDSC, the original paper from Apolloni et al. addressed a phenotype of 
MSC-2 between MDSC and tumor associated macrophages, as proved by the loss of Gr1 expression as well as an 
upregulation of F4/8035. The expression of F4/80 on Gr1− cells after oleate treatment illustrated the macrophage 
phenotype. Furthermore, we found an elevated level of CD163 and CD206 in oleate treated Gr1− cells compared 
with either BSA incubated Gr1− cells or oleate treated Gr1+ cells. These data implied the characterization of Gr1− 
cells as M2- like tumor associated macrophages (Fig. 7; Supp. Figure 4). In line, both oleate induced lipid drop-
lets formation and DGAT inhibitor mediated inhibition of lipid droplets were confirmed in Gr1− but not Gr1+ 
subsets. Previous data from Camell et al. demonstrated that high oleic diet increases the expression of CD206 on 
macrophages isolated from mesenteric adipose tissue36. Meanwhile, tissue resident macrophages, for instance 
Kupffer cell, have been reported to explain an elevated protein level of CD206 after oleate but not palmitate treat-
ment in vitro27. All these data illustrate the potent effect of oleate on either bone marrow precursor cells or mature 
macrophages. Thus, we concluded that oleate induces a change in the bone marrow derived myeloid cells into an 
anti-inflammatory macrophage phenotype, paralleled by a potent immunosuppressive capacity.
Cytokine profiling of the purified Gr1− populations (Fig. 7E) tells us that both, IL-6 and TNFα, which are 
related to tumor associated macrophages, were enriched in only oleate but not in the control or stearate group, 
implying a strong relationship between oleate metabolism and the formation of tumor associated macrophages 
in cytokine level. On the other hand, for IL-1β and IL-10, which are classified as markers for anti-inflammatory 
macrophages and MDSCs, there is no difference between the stearate and the oleate group. This tells us, that 
FFA treatment pushes the cells to an anti-inflammatory phenotype, while oleate treated cells specifically are dis-
tinguishable not only functionally but also phenotypically (surface marker as well as cytokine production). The 
neglectable amount of IL-4 in these myeloid cells confirmed again, that the oleate induced suppression is inde-
pendent of this cytokine. Besides, none of the myeloid cells in the experiment could produce IFNγ, consistent 
with the conclusion that T cell derived IFNγ is responsible for the initiation of NO production.
With the present study we further elucidate previous data on the tumor-promoting effect of an oleate-enriched 
diet and propose potential consequences of free fatty acid release by tumor cells in the tumor microenvironment. 
Our data not only reveal a specific effect for sodium oleate and linoleate on myeloid precursors but in addition 
provide a mode of action how the presence of unsaturated fatty acids affects tumor escape by the functional 
induction of myeloid suppressor cells.
Material and Methods
Mice and cell lines. All animal protocols were approved by the regional animal study committee of Berlin 
(Germany, LaGeSo) and all methods were performed in accordance with the relevant guidelines and regulations 
as published by the study committee.
Six- to eight-week-old female BALB/c mice were obtained from Harlan Winkelmann (Borchen, Germany). 
The MSC-2 cell line was kindly provided by Professor Ghiringhelli (Institut National de la Santé et de la Recherche 
Médicale (INSERM) U866, Dijon, France). Cells were passaged at 37 °C in a 5% CO2 atmosphere in Dulbecco’s 
modified Eagle’s medium supplemented with 10% fetal bovine serum (Invitrogen GmbH, Darmstadt, Germany) 
and penicillin/streptomycin (100 U/ml/ 100 µg/ml, Sigma-Aldrich Chemie GmbH, Munich, Germany). The E.G7 
OVA cell line was bought from ATCC (ATCC ®CRL-2113TM). The RAW264.7 cell line was passaged in the same 
condition as MSC-2 cell line in the presence of 1 mM sodium pyruvate. T cells were cultured in RPMI medium 
supplemented with 10% fetal bovine serum (Invitrogen GmbH), penicillin/streptomycin (100 U/ml/ 100 µg/ml, 
Sigma-Aldrich Chemie GmbH) and 50 µM β-mercaptoethanol (Sigma-Aldrich Chemie GmbH).
Fatty acid-albumin preparation. All fatty acid salts were solubilized in water. Fatty acid salts were dis-
solved in hot distilled water and added rapidly to proper cell culture medium with fatty acid-free BSA at a molar 
ratio of 8:1 (fatty acid salt: albumin). Fatty acid-albumin complex solutions were freshly prepared prior to each 
experiment.
Antibodies and chemicals. If not indicated otherwise, all chemicals were obtained from Sigma-Aldrich 
Chemie GmbH. The following antibodies were applied for Western blot analyses: polyclonal anti-NOS (pan) 
(Cell Signaling Technology, Leiden, The Netherlands) and anti-β-actin (clone AC-15) and horseradish 
peroxidase-labeled polyclonal rabbit anti-mouse and polyclonal goat anti-rabbit antibodies (Dako, Hamburg, 
Germany).
The following antibodies were applied for flow cytometric analysis: PE-CD80 (clone 16-10A1) and 
APC-Cy7-CD11b (clone M1/70) from BD Bioscience (Heidelberg, Germany); APC-MHCII (clone M5/114.15.2), 
PE-Cy7-Gr1 (clone RB6-8C5), Percp-Cy5.5-CD11c (clone N418) and PE-Cy7-CD11b (clone M1/70) are 
from eBioscience (Frankfurt, Germany); Percp-Cy5.5-CD4 (clone GK1.5), APC-CD4 (clone GK1.5) are from 
Biolegend GmbH (Fell, Germany). BODIPY was obtained from Life Technologies (Carlsbad, CA, USA).
Inhibition of lipid droplets formation. The combination of diacylglycerol acyltransferase DGAT inhib-
itors (iDGAT) (DGAT 1 inhibitor: A922500; DGAT2 inhibitor: PF-06424439, both Sigma-Aldrich Chemie 
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GmbH) served to block the lipid droplets formation. MSC-2 cells were pre-incubated with 100 nM iDGAT for 
1 h, and then cultured with the indicated FFA in the presence of 100 nM iDGAT for additional 24 h.
Primary CD11b+ cell isolation. Mice were subcutaneously grafted with 4 × 106 MCA203 cells. After either 
7 or 14 days, cells from control and tumor bearing mice were sorted as described below. Briefly, tumor tissues 
were bathed in 70% isopropanol for 30 s and then transferred to a Petri dish. Tumors were minced into pieces 
<3 mm in diameter and digested in 2 mg/ml collagenase type D at 37 °C for 1 h. The digested tissue pieces were 
then pressed through a 100 µm Falcon® nylon cell strainer (Corning, NY, USA). Spleen single cell suspension 
was prepared by standard procedures. Purified cell suspensions were incubated with PE-Cy7-labeled anti-CD11b 
antibodies for 10 min on ice and sorted by FACSJazz (BD Bioscience). CD11b+ cells were subsequently cultured 
at the indicated concentrations in the presence of either BSA (the same amount as used for sodium oleate) or 
0.2 mM sodium oleate in 96-well plates for 24 h and then co-cultured with 3 × 105 purified CD4+ T cells to analyze 
T cell proliferation as described below.
Bone marrow-derived myeloid cells. Bone marrow cells were isolated as previously described37. Briefly, 
the cavities of femur and tibia bones of BALB/c mice were flushed with PBS. The single cell suspensions were cul-
tured in high glucose DMEM (4.5 g/L D-glucose) supplemented with 10% fetal calf serum, 100 U/ml penicillin, 
100 µg/ml streptomycin and 40 ng/ml granulocyte macrophage colony-stimulating factor (GM-CSF, Peprotech, 
Hamburg, Germany). After 24 h of incubation, non-adherent macrophage progenitor cells were isolated and cul-
tured in the presence of 10 ng/ml IL-4 (Peprotech), 0.2 mM BSA/sodium stearate or 0.2 mM BSA/sodium oleate 
plus 40 ng/ml GM-CSF for 7 days in 6-well plates. Medium was renewed every other day.
Flow cytometry. Flow cytometric analyses were performed using standard procedures. In brief, 2 × 105–108 
cells were harvested and resuspended in 50 µl PBS/0.5% BSA buffer in the presence of the indicated antibodies 
for 10 min on ice. For BODIPY staining, cells were labeled by 0.2 µg/ml BODIPY®493/503 (Life Technologies) 
and incubated in 37 °C for 15 min and washed by PBS. Data acquisition was performed using a FACSCANTO II 
device (BD Bioscience) and analyzed by FlowJo software (Tree Star, Inc., Oregon, USA).
T cell suppression assay. For the T cell proliferation assay, syngeneic CD4+ /CD8+ T cells were isolated 
from spleens and lymph nodes of healthy mice and purified via MACS (Miltenyi Biotec, Bergisch Gladbach, 
Germany). The purity of CD4 and CD8 sorting was >98%. T cells were stained with 0.5 µM carboxyfluores-
cein succinimidyl ester (CFSE) for 10 min at 37 °C followed by thorough washing and resuspension in T cell 
medium. Five µg/ml Concanavalin A or 96-well plates pre-coated with 5 µg/ml anti-CD3 (clone 2C11) plus 
5 µg/ml anti-CD28 (clone 37.51E1; both BD Pharmingen) served for T cell stimulation as indicated. Stimulated 
CFSE-labeled T cells were cultured in the presence or absence or either MSC-2 cells (pre-treated with 100 µg/ml 
mitomycin C in PBS for 10 min at 37 °C in a 5% CO2 atmosphere) or bone marrow-derived myeloid cells in var-
ious ratios as indicated. After 72 h, the cultured cells were washed and gated on lymphocytes. The CFSE dilution 
due to cell division was analyzed by a FACSCANTO II device (BD Bioscience) using the FlowJo software (Tree 
Star).
Cytotoxicity Assay. CD8+ T cells from wild-type OT-1 mice were differentiated into CTLs as described 
before38. Briefly, CD8+ T cells were isolated from spleens of wild-type OT-1 mice and stimulated by 2 µg/ml 
anti-CD3, 4 µg/ml anti-CD28 and 100 U/ml rIL-2 for 48 hours. CTLs were then polarized in the presence of 
100 U/ml rIL-2 and medium was refreshed every two days. Meanwhile, bone marrow derived myeloid cells were 
polarized as described before. After 6 to 9 days, CTLs were harvested and cocultured with purified Gr1− myeloid 
cells from different group for 18 hours. 1 × 105 CTLs were then cocultured with carboxyfluorescein succinimidyl 
ester (CFSE) labelled EG7-Ova T-cell lymphoma cells for 90 min. Cells were stained with Annexin V–eFluor 450 




Relative Cytotoxicity %Annexin V(x) %Annexin V(E: T 0: 1)
%Annexin V(Control group E: T 2: 1) %Annexin V(E: T 0: 1)
Nitric oxide measurements. MSC-2 cells or bone marrow-derived myeloid cells were stimulated with 
murine IFNγ (Peprotech) for either 24 or 48 h. NO production was measured in the supernatant as nitrite con-
centration using the Griess assay as described in the manufacturer’s instructions (Promega GmbH, Mannheim, 
Germany).
Arginase activity detection. Arginase activity was determined by measuring the amount of urea gen-
erated from the hydrolysis of L-arginine, as described previously39. Briefly, isolated cells were lysed in the pres-
ence of 100 μl lysis solution (0.1% Triton X-100, 10 mM MnCl2, 25 mM Tris-HCl). In brief, lysate of CD11b+ 
Gr1+ cells was incubated with L-arginine. The reaction was stopped with 1 M sulfuric acid. Subsequently, 
α-isonitrosopropiophenone was added followed by boiling for 30 min. The concentration of urea was determined 
at 540 nm absorbance by the Infinite® F50/Robotic ELISA plate reader (TECAN, Männedorf, Switzerland). One 
U enzyme activity was defined as the amount of enzyme that catalyzes the formation of 1 μmol of urea per min.
Western blot analysis. For iNOS, STAT1, pSTAT1, STAT3, pSTAT3 expression detection, 106 cells were 
lysed in RIPA buffer (Life Technologies). Western blot was performed via standard procedure40. Densitometric 
analysis was performed with the Fuji MultiGauge software (Fujifilm, Düsseldorf, Germany).
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Oil-red-O Staining. Oil-red-O staining was performed as described previously41. Briefly, dye solution was 
prepared as follows: oil-red-O (0.5% w/v) were dissolved overnight in isopropanol. The solution was filtered and 
bi-distilled water was added. After 16 h at 4 °C, the precipitate was removed by filtration and the supernatant was 
stored at room temperature. MSC-2 cell layers were washed with PBS and fixed with 4% phosphate-buffered 
formaldehyde for 15 min at room temperature, stained with the oil-red-O dye solution for 1 h and subsequently 
washed with 70% ethanol. Cells were visualized by phase contrast microscopy (Zeiss Microimaging, Oberkochen, 
Germany).
Cytokine Measurement. Supernatants from either myeloid cell-T cell co-culture system or primary bone 
marrow cells were used for cytokine measurement. Primary myeloid cells were incubated in the presence of 
GM-CSF plus FFAs for 7 days. 1 × 106 Gr1− subsets were purified via MACS (Miltenyi Biotec, Bergisch Gladbach, 
Germany) and stimulated with 1 µg/ml LPS for 24 hours. The supernatant was collected for analysis. CBA inflam-
mation kit (BD Pharmingen) was used in accordance with the manufacturer’s instructions. Samples were meas-
ured using a FACSCANTO II device and data were analyzed via FCAP array Software (BD Biosciences).
Statistical Analysis. Statistical significance of differences between the experimental groups were deter-
mined by Student’s t-test or factorial analysis of variance and the respective post hoc tests (Tukey’s and Dunnett’s 
multiple comparisons test) using GraphPad Prism software (GraphPad Software, La Jolla, CA).
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